the future of enfortumab vedotin in different stages bladder cancer
Published 1 year ago • 162 plays • Length 1:08Download video MP4
Download video MP3
Similar videos
-
3:07
enfortumab vedotin in urothelial cancer
-
2:09
enfortumab vedotin for bladder cancer
-
2:20
ev-201: enfortumab vedotin for bladder cancer
-
1:05
future endeavours with adcs in bladder cancer
-
0:30
enfortumab vedotin plus pembrolizumab for advanced urothelial carcinoma
-
1:27
erdafitinib and enfortumab vedotin in pretreated fgfr2/3-mutant bladder cancer
-
1:09
enfortumab vedotin: targeting bladder cancer
-
2:58
ev-201: enfortumab vedotin for cisplatin-ineligible bladder cancer
-
0:49
evolving landscape of urothelial cancer treatment: erdafitinib or enfortumab vedotin?
-
3:25
enfortumab vedotin with pembrolizumab for bladder cancer
-
0:35
ev-302: 1l enfortumab vedotin in combination with pembrolizumab
-
4:16
unite: enfortumab vedotin in advanced urothelial cancer
-
0:34
pembrolizumab plus enfortumab vedotin for bladder cancer
-
3:14
the role of enfortumab vedotin in earlier lines and stages of urothelial cancer | arjun balar
-
1:58
enfortumab vedotin for the treatment of advanced urothelial cancer
-
2:09
ev-103: neoadjuvant enfortumab vedotin in cis-ineligible mibc
-
1:59
enfortumab vedotin as monotherapy in heavily pretreated mcrpc
-
6:01
enfortumab vedotin plus pembrolizumab improves overall survival for advanced bladder cancer
-
0:50
enfortumab vedotin appears well-tolerated and active in advanced bladder cancers